Oppenheimer & Co’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-17,294
| Closed | -$390K | – | 1649 |
|
|
2024
Q3 | $390K | Sell |
17,294
-6,745
| -28% | -$152K | 0.01% | 1130 |
|
|
2024
Q2 | $468K | Buy |
24,039
+13,456
| +127% | +$262K | 0.01% | 1021 |
|
|
2024
Q1 | $397K | Sell |
10,583
-3,537
| -25% | -$133K | 0.01% | 1076 |
|
|
2023
Q4 | $790K | Buy |
14,120
+3,588
| +34% | +$201K | 0.01% | 796 |
|
|
2023
Q3 | $434K | Sell |
10,532
-182
| -2% | -$7.51K | 0.01% | 996 |
|
|
2023
Q2 | $598K | Sell |
10,714
-145
| -1% | -$8.1K | 0.01% | 913 |
|
|
2023
Q1 | $606K | Sell |
10,859
-5,881
| -35% | -$328K | 0.01% | 872 |
|
|
2022
Q4 | $610K | Sell |
16,740
-3,280
| -16% | -$120K | 0.01% | 855 |
|
|
2022
Q3 | $570K | Buy |
20,020
+9,973
| +99% | +$284K | 0.01% | 845 |
|
|
2022
Q2 | $455K | Buy |
10,047
+2,244
| +29% | +$102K | 0.01% | 951 |
|
|
2022
Q1 | $594K | Buy |
+7,803
| New | +$594K | 0.01% | 939 |
|